Skip to main content
Equibles

SAILIFE · Sai Life Sciences Limited · Documents

Use SAILIFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SAILIFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,929.00 INR +24.45 (+1.28%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 123.33K Avg daily vol (3M) 93.88K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call New Q2 2027 earnings call Held Nov 6, 2026
2026
Nov 6
Earnings call
Q2 FY27 revenue rises 23% as EBITDA margin holds at 28%

Sai Life Sciences Limited reported Q2 FY27 revenue growth of 23% year-on-year and a 28% EBITDA margin. Capex reached INR621 crores in the first six months of fiscal '27; a 225 KL expansion moved to early Q3 of fiscal '28.

5 source passages
welcome to Sai Life Sciences Limited Q2 FY27 Earnings Conference Call. For Q2 FY27, our revenues grew by 23% year-on-year EBITDA for the quarter was 28% of the revenue and was in line with the year-on-year margin trajectory. we have incurred expenditure of approximately INR621 crores during the first six months of fiscal '27, of which INR358 crores was incurred in Q2. the commissioning of the additional capacity of 225 KL is now expected to be available by early Q3 of fiscal '28, compared with our earlier timelines. Open the document at this passage
Showing 1–4 of 4 documents